Pressure grows on NHS to stump up for £60,000 'miracle' dementia drugs as drug watchdog reopens talks to give it the green light

7 March 2025

“About 40 per cent of patients who are treated with this class of drugs develop brain swelling and bleeding. In most people, this isn't too serious,” said Professor Rob Howard (UCL Psychiatry) on the Alzheimer’s drugs lecanemab and donanemab.